This prompted us to perform a preclinical placebo-controlled intervention study assessing potential anti-pathogenic and immune-modulatory effects of garlic-EO in acute experimental campylobacteriosis applying the secondary abiotic interleukin-10 deficient (IL-10-/-) mouse infection and inflammation model [32]. This evidence concerns the gene IL10 and campylobacteriosis.